Pathological complete response to neoadjuvant chemotherapy, but not the addition of carboplatin, is associated with improved survival in Chilean triple negative breast cancer patients: a report of real world data-Reference-Cited by-同舟云学术

Pathological complete response to neoadjuvant chemotherapy, but not the addition of carboplatin, is associated with improved survival in Chilean triple negative breast cancer patients: a report of real world data

Published:2021-02-01 Issue: Volume:15 Page:
ISSN:1754-6605
Container-title:ecancermedicalscience
language:
Short-container-title:ecancer

Author:

Walbaum Benjamín,Acevedo Francisco,Medina Lidia,Bravo M Loreto,Merino Tomás,Camus Mauricio,Domínguez Francisco,Mondaca Sebastián,Galindo Héctor,Nervi Bruno,Ibáñez Carolina,Madrid Jorge,Muñiz Sabrina,Peña José,Koch Érica,Garrido Marcelo,Pinto Mauricio P,Sánchez Cesar

Publisher

Ecancer Global Foundation

Subject

Cancer Research,Oncology

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. [Artículo traducido] Efectividad y seguridad del tratamiento neoadyuvante del cáncer de mama triple negativo en la vida real;Farmacia Hospitalaria;2024-07

2. Effectiveness and safety of neoadjuvant therapy in triple-negative breast cancer in a real-world population;Farmacia Hospitalaria;2024-05

3. Comparison of neoadjuvant chemotherapy response and prognosis between HR-low/HER2-negative BC and TNBC: an exploratory real-world multicentre cohort study;Frontiers in Endocrinology;2024-03-19

4. Real-world data on triple-negative breast cancer in Latin America and the Caribbean;ecancermedicalscience;2023-11-21

5. Real-life analysis of neoadjuvant-therapy-associated benefits for pathological complete response and survival in early breast cancer patients - role of trastuzumab in HER2+ BC and platinum in TNBC;Frontiers in Oncology;2023-01-24